BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18407589)

  • 1. Troglitazone, a peroxisome proliferator-activated receptor gamma ligand, induces growth inhibition and apoptosis of HepG2 human liver cancer cells.
    Zhou YM; Wen YH; Kang XY; Qian HH; Yang JM; Yin ZF
    World J Gastroenterol; 2008 Apr; 14(14):2168-73. PubMed ID: 18407589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A ligand for peroxisome proliferator activated receptor gamma inhibits cell growth and induces apoptosis in human liver cancer cells.
    Toyoda M; Takagi H; Horiguchi N; Kakizaki S; Sato K; Takayama H; Mori M
    Gut; 2002 Apr; 50(4):563-7. PubMed ID: 11889080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligands of peroxisome proliferator-activated receptor-gamma induce apoptosis in AR42J cells.
    Masamune A; Satoh K; Sakai Y; Yoshida M; Satoh A; Shimosegawa T
    Pancreas; 2002 Mar; 24(2):130-8. PubMed ID: 11854617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Troglitazone, a peroxisome proliferator-activated receptor gamma (PPAR gamma ) ligand, selectively induces the early growth response-1 gene independently of PPAR gamma. A novel mechanism for its anti-tumorigenic activity.
    Baek SJ; Wilson LC; Hsi LC; Eling TE
    J Biol Chem; 2003 Feb; 278(8):5845-53. PubMed ID: 12475986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
    Pandhare J; Cooper SK; Phang JM
    J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone Enhances the Apoptotic Response of DLD-1 Colon Cancer Cells to Photodynamic Therapy.
    Park H; Ko SH; Lee JM; Park JH; Choi YH
    Yonsei Med J; 2016 Nov; 57(6):1494-9. PubMed ID: 27593880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro.
    Liu JJ; Huang RW; Lin DJ; Peng J; Wu XY; Lin Q; Pan XL; Song YQ; Zhang MH; Hou M; Chen F
    Ann Oncol; 2005 Mar; 16(3):455-9. PubMed ID: 15642706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
    Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
    Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of peroxisome proliferator-activated receptor-gamma ligand troglitazone on colon cancer cell growth].
    Koirala K; Wan YL; Liu YC; Wang X; Cui W; Wang CL; Chen HN; Wang HY; Zhu J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 38(4):385-8. PubMed ID: 16892143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.
    Akasaki Y; Liu G; Matundan HH; Ng H; Yuan X; Zeng Z; Black KL; Yu JS
    J Biol Chem; 2006 Mar; 281(10):6165-74. PubMed ID: 16319070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.
    Ming M; Yu JP; Meng XZ; Zhou YH; Yu HG; Luo HS
    World J Gastroenterol; 2006 Dec; 12(45):7263-70. PubMed ID: 17143939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity.
    Yamakawa-Karakida N; Sugita K; Inukai T; Goi K; Nakamura M; Uno K; Sato H; Kagami K; Barker N; Nakazawa S
    Cell Death Differ; 2002 May; 9(5):513-26. PubMed ID: 11973610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peroxisome proliferator-activated receptor (PPAR)-gamma expression in human vascular smooth muscle cells: inhibition of growth, migration, and c-fos expression by the peroxisome proliferator-activated receptor (PPAR)-gamma activator troglitazone.
    Benson S; Wu J; Padmanabhan S; Kurtz TW; Pershadsingh HA
    Am J Hypertens; 2000 Jan; 13(1 Pt 1):74-82. PubMed ID: 10678274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone inhibits isolated cell proliferation, and induces apoptosis in isolated rat mesangial cells.
    Tsuchiya T; Shimizu H; Shimomura K; Mori M
    Am J Nephrol; 2003; 23(4):222-8. PubMed ID: 12840598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
    Akinyeke TO; Stewart LV
    Cancer Biol Ther; 2011 Jun; 11(12):1046-58. PubMed ID: 21525782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells.
    Wang J; Lv X; Shi J; Hu X; DU Y
    Biomed Environ Sci; 2011 Aug; 24(4):391-9. PubMed ID: 22108328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth inhibition and differentiation of pancreatic cancer cell lines by PPAR gamma ligand troglitazone.
    Kawa S; Nikaido T; Unno H; Usuda N; Nakayama K; Kiyosawa K
    Pancreas; 2002 Jan; 24(1):1-7. PubMed ID: 11741176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Troglitazone inhibits tumor growth in hepatocellular carcinoma in vitro and in vivo.
    Yu J; Qiao L; Zimmermann L; Ebert MP; Zhang H; Lin W; Röcken C; Malfertheiner P; Farrell GC
    Hepatology; 2006 Jan; 43(1):134-43. PubMed ID: 16374840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.